NEW YORK (GenomeWeb News) – Rubicon Genomics has signed an agreement to provide Kreatech Diagnostics with its OmniPlex-D whole-genome amplification technology.
Under the agreement, Rubicon will provide Kreatech with reagents incorporating elements of the OmniPlex technology, which Kreatech will use in the manufacture of its Poseidon fluorescence in situ hybridization probes. Financial and other terms of the agreement were not disclosed.
The OmniPlex technology has been designed to "deliver sufficient quantities of high-quality species-specific or locus-specific RNA or DNA to increase the sensitivity and specificity of analyses of biological samples for biomedical research and clinical medicine," Ann Arbor, Mich.-based Rubicon said in a statement.